Azura Ophthalmics
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED) (NCT06329791) | Azura Ophthalmics | 2024-05-28 |
| Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) (NCT04391959) | Azura Ophthalmics | 2020-07-17 |
| Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD) (NCT04314362) | Azura Ophthalmics | 2020-07-14 |
| An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD) (NCT03972501) | Azura Ophthalmics | 2019-10-04 |
| A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) (NCT03652051) | Azura Ophthalmics | 2018-09-10 |
Track Azura Ophthalmics automatically
Every clearance here is in the API, with alerts when new ones post.